News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regado Biosciences, Inc. (RGDO) Selects TransPerfect Trial Interactive Platform as its Study Start-Up and eTMF Solution


10/21/2013 9:38:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--TransPerfect, a leading provider of e-clinical solutions to the life sciences industry, today announced that Regado Biosciences has implemented TransPerfect’s Trial Interactive solution to streamline study start-up and electronic trial master file (eTMF) management for its ongoing 500-site Phase III global study (REGULATE-PCI). Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based management of clinical trials.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES